Summary
The distribution of i.v.-injected tritiated oxypertine was studied in mice and cats by an autoradiographic technique. The compound rapidly accumulated in the lung, kidney, liver, adrenal medulla and brain. Later on the radioactivity concentrated also in bone marrow, pancreas and salivary glands, and still more in the gall-bladder and gastro-intestinal contents. The adrenal medulla, liver and kidney retained their activity for a long time. The hippocampus, thalamus and cerebral cortex were the most active sites in the brain. Oxypertine passed the placental barrier and was found especially in the foetal membranes and placenta and in the liver and gut contents of the foetus.
Similar content being viewed by others
References
Airaksinen, M. M., and P. J. Neuvonen: Distribution and excretion of tritium-labelled Oxypertine (Win 18.501-T) in rats. To be published.
Appelgren, L.-E., E. Hansson, and C. G. Schmiterlöw: The accumulation and metabolism of C14 labeled nicotine in the brain of mice and cats. Acta physiol. scand. 56, 249–247 (1962).
Calwell, W. P. K., M. Jacobsen, and A. Skarbek: A comparative study of oxypertine and trifluoperazine in chronic schizophrenia. Brit. J. Psychiat. 110, 520–530 (1964).
Durell, J., and W. Pollin: A trial on chronic schizophrenic patients of oxypertine, a psychotropic drug with an indole ring. Brit. J. Psychiat. 109, 687–691 (1963).
Flament, J., J. G. Lofft, and F. von Mendelssohn: Clinical investigation of the psychopharmacological effects of Winthrop 18.501-2. Neuropsychopharmacology 3, 275–278 (1962).
Hansson, E., and C. G. Schmiterlöw: Physiological disposition and fate of C14-labelled nicotine in mice and rats. J. Pharmacol. exp. Ther. 137, 91–102 (1962).
Hollister, L. E., J. E. Overall, I. Kimbell, J. L. Bennett, F. Mayer, and E. Caffey: Oxypertine in newly admitted schizophrenics. J. New Drugs 1963, 26–31.
Matsuoka, M., S. Ishii, N. Shimizu, and R. Imaizumi: Effect of Win 18.501-2 on the content of catecholamines and the number of catecholamine-containing granules in the rabbit hypothalamus. Experientia (Basel) 21, 121–123 (1965).
Pohto, P.: Personal communication (1965).
Sjöstrand, S. E., G. B. Cassano, and E. Hansson: The distribution of 35S-chlorpromazine in mice studied by whole body autoradiography. Arch. int. Pharmacodyn. 156, 34–47 (1965).
Skarbek, A., and M. Jacobsen: Oxypertine. A review of clinical experience. Brit. J. Psychiat. 111, 1173–1179 (1965).
Spector, S., K. Melmon, and S. Sjoerdsma: Evidence for rapid turnover of norepinephrine in rat heart and brain. Proc. Soc. exp. Biol. (N. Y.) 111, 79–81 (1962).
Ullberg, S.: Autoradiographic localization in the tissue of drugs and metabolites. Proceeding of the First International Pharmacological Meeting, vol. 5, pp. 29 to 36 (1963).
Wylie, D. W., and S. Archer: Structure-activity relationships of 1-(3-Indolyl)-alkyl-4-arylpiperazines, a new series of tranquillisers. J. med. pharm. Chem. 5, 932–943 (1962).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Airaksinen, M.M., Idänpään-Heikkilä, J.E. Radioautographic study on the distribution of oxypertine (Win 18,501) in mice and cats. Psychopharmacologia 10, 400–408 (1967). https://doi.org/10.1007/BF00403980
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00403980